It’s not a miracle solution, but it’s still a huge hope for the 8.5 million obese people in France. Wegovy, a drug from Danish pharmaceutical giant Novo Nordisk, should be available on the market soon. Popular on social networks under the name Ozempic, equivalent to diabetes, “Wegovy has received its marketing authorization and its price is now being discussed by the High Health Authority“, he trusts Figaro National Agency for the Safety of Medicines (ANSM).
This weight loss drug, which is already available in the United States from 2021, shows quite impressive effectiveness in a context where obesity treatment options remain limited. The drug causes patients to lose 5 to 20% of their weight (an average of 15 kilograms) after one year of treatment. Very attractive results that make health authorities afraid of abuse by people who want to lose just a few…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.